Implementing Health Canada’s Newly Revised Regulation 0069
We respect your privacy, by clicking ‘Watch On-Demand’ you agree to having your details passed onto the sponsors who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
The revised 0069 guideline was issued January 28th this year, outlining detailed regulations for the distribution of temperature control pharmaceuticals in Canada. With the implementation date being April 28th 2011, shippers and cold chain stakeholders are keen to understand these new regulatory provisions. This presentation recorded at the from the 1st Cold Chain & Temperature Control Distribution Online Summit, will discuss new regulatory requirements in Canada, giving examples of compliance and non-compliance regarding:
- Products in transit: stability data requirements and temperature mapping
- Temperature monitoring for CRT
- Risk evaluation and mitigation recommended approaches
- Containers and container labeling, including the use of IATA label
--|--EventPDF--||--
 | Have Your Say Rate this feature and give us your feedback in the comments section below |
Presenters:
Sarah Skuce
Compliance Specialist
Health Canada
We respect your privacy, by clicking ‘Watch On-Demand’ you agree to having your details passed onto the sponsors who may promote similar products and services related to your area of interest subject to their privacy policy. You have the right to object. In addition, you will receive our e-newsletter, including information on related online learning opportunities. For further information on how we process and monitor your personal data, and information about your privacy and opt-out rights, click here.
Sponsored By:
